{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T07:41:01Z","timestamp":1763106061582,"version":"3.33.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81172186"],"award-info":[{"award-number":["81172186"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2018CFB504"],"award-info":[{"award-number":["2018CFB504"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guidance Foundation of Renmin Hospital of Wuhan University","award":["RMYD2018M67"],"award-info":[{"award-number":["RMYD2018M67"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13564-8","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T10:15:35Z","timestamp":1737800135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical implications of DNA ploidy, stroma, and nucleotyping in predicting peritoneal metastasis risk for gastric cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Jingwen","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shasha","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfeng","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiatong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingping","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,25]]},"reference":[{"issue":"1","key":"13564_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.canlet.2011.10.004","volume":"315","author":"J Cheng","year":"2012","unstructured":"Cheng J, Deng H, Xiao B, Zhou H, Zhou F, Shen Z, et al. piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells. Cancer Lett. 2012;315(1):12\u20137.","journal-title":"Cancer Lett"},{"issue":"1","key":"13564_CR2","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12967-018-1582-8","volume":"16","author":"J Cheng","year":"2018","unstructured":"Cheng J, Zhuo H, Xu M, Wang L, Xu H, Peng J, et al. Regulatory network of circRNA-miRNA-mRNA contributes to the histological classification and disease progression in gastric cancer. J Translational Med. 2018;16(1):216.","journal-title":"J Translational Med"},{"key":"13564_CR3","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.12659\/MSM.916475","volume":"25","author":"Z Tan","year":"2019","unstructured":"Tan Z. Recent advances in the Surgical treatment of Advanced Gastric Cancer: a review. Med Sci Monitor: Int Med J Experimental Clin Res. 2019;25:3537\u201341.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"issue":"8","key":"13564_CR4","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.3748\/wjg.v22.i8.2403","volume":"22","author":"A Digklia","year":"2016","unstructured":"Digklia A, Wagner AD. Advanced gastric cancer: current treatment landscape and future perspectives. World J Gastroenterol. 2016;22(8):2403\u201314.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"13564_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1046\/j.1365-2168.2000.01360.x","volume":"87","author":"CH Yoo","year":"2000","unstructured":"Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87(2):236\u201342.","journal-title":"Br J Surg"},{"issue":"38","key":"13564_CR6","doi-asserted-by":"publisher","first-page":"13667","DOI":"10.3748\/wjg.v20.i38.13667","volume":"20","author":"R Santoro","year":"2014","unstructured":"Santoro R, Ettorre GM, Santoro E. Subtotal gastrectomy for gastric cancer. World J Gastroenterol. 2014;20(38):13667\u201380.","journal-title":"World J Gastroenterol"},{"issue":"41","key":"13564_CR7","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.3748\/wjg.v19.i41.6979","volume":"19","author":"F Coccolini","year":"2013","unstructured":"Coccolini F, Gheza F, Lotti M, Virz\u00ec S, Iusco D, Ghermandi C, et al. Peritoneal carcinomatosis. World J Gastroenterol. 2013;19(41):6979\u201394.","journal-title":"World J Gastroenterol"},{"key":"13564_CR8","doi-asserted-by":"crossref","unstructured":"Gronau F, Feldbruegge L, Oberwittler F, Gonzalez-Moreno S, Villeneuve L, Eveno C et al. HIPEC in peritoneal metastasis of gastric origin: a systematic review of regimens and techniques. J Clin Med. 2022;11(5).","DOI":"10.3390\/jcm11051456"},{"issue":"8","key":"13564_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11912-019-0820-4","volume":"21","author":"FM Johnston","year":"2019","unstructured":"Johnston FM, Beckman M. Updates on management of gastric Cancer. Curr Oncol Rep. 2019;21(8):67.","journal-title":"Curr Oncol Rep"},{"issue":"4","key":"13564_CR10","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/jso.2930590405","volume":"59","author":"S Abe","year":"1995","unstructured":"Abe S, Yoshimura H, Tabara H, Tachibana M, Monden N, Nakamura T, et al. Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome. J Surg Oncol. 1995;59(4):226\u20139.","journal-title":"J Surg Oncol"},{"key":"13564_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-230X-11-19","volume":"11","author":"Z Wang","year":"2011","unstructured":"Wang Z, Chen JQ. Imaging in assessing hepatic and peritoneal metastasis of gastric cancer: a systematic review. BMC Gastroenterol. 2011;11:19.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"13564_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41467-020-20429-0","volume":"12","author":"D Chen","year":"2021","unstructured":"Chen D, Liu Z, Liu W, Fu M, Jiang W, Xu S, et al. Predicting postoperative peritoneal metastasis in gastric cancer with serosal invasion using a collagen nomogram. Nat Commun. 2021;12(1):179.","journal-title":"Nat Commun"},{"issue":"1","key":"13564_CR13","doi-asserted-by":"publisher","first-page":"e2032269","DOI":"10.1001\/jamanetworkopen.2020.32269","volume":"4","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Liang X, Wang W, Chen C, Yuan Q, Zhang X, et al. Noninvasive prediction of Occult Peritoneal Metastasis in Gastric Cancer using deep learning. JAMA Netw open. 2021;4(1):e2032269.","journal-title":"JAMA Netw open"},{"issue":"4","key":"13564_CR14","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.cell.2013.10.011","volume":"155","author":"T Davoli","year":"2013","unstructured":"Davoli T, Xu AW, Mengwasser KE, Sack LM, Yoon JC, Park PJ, et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell. 2013;155(4):948\u201362.","journal-title":"Cell"},{"issue":"6673","key":"13564_CR15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/32688","volume":"392","author":"DP Cahill","year":"1998","unstructured":"Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, et al. Mutations of mitotic checkpoint genes in human cancers. Nature. 1998;392(6673):300\u20133.","journal-title":"Nature"},{"issue":"7","key":"13564_CR16","first-page":"2815","volume":"6","author":"T Furuya","year":"2000","unstructured":"Furuya T, Uchiyama T, Murakami T, Adachi A, Kawauchi S, Oga A, et al. Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers. Clin cancer Research: Official J Am Association Cancer Res. 2000;6(7):2815\u201320.","journal-title":"Clin cancer Research: Official J Am Association Cancer Res"},{"issue":"2\u20134","key":"13564_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000323504","volume":"133","author":"O Reish","year":"2011","unstructured":"Reish O, Regev M, Kanesky A, Girafi S, Mashevich M. Sporadic aneuploidy in PHA-stimulated lymphocytes of trisomies 21, 18, and 13. Cytogenet Genome Res. 2011;133(2\u20134):184\u20139.","journal-title":"Cytogenet Genome Res"},{"issue":"8","key":"13564_CR18","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41588-018-0165-1","volume":"50","author":"CM Bielski","year":"2018","unstructured":"Bielski CM, Zehir A, Penson AV, Donoghue MTA, Chatila W, Armenia J, et al. Genome doubling shapes the evolution and prognosis of advanced cancers. Nat Genet. 2018;50(8):1189\u201395.","journal-title":"Nat Genet"},{"issue":"1 Suppl","key":"13564_CR19","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1067\/msy.2002.119306","volume":"131","author":"H Baba","year":"2002","unstructured":"Baba H, Korenaga D, Kakeji Y, Haraguchi M, Okamura T, Maehara Y. DNA ploidy and its clinical implications in gastric cancer. Surgery. 2002;131(1 Suppl):S63\u201370.","journal-title":"Surgery"},{"issue":"3","key":"13564_CR20","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/jcp.21991","volume":"222","author":"V D\u2019Urso","year":"2010","unstructured":"D\u2019Urso V, Collodoro A, Mattioli E, Giordano A, Bagella L. Cytometry and DNA ploidy: clinical uses and molecular perspective in gastric and lung cancer. J Cell Physiol. 2010;222(3):532\u20139.","journal-title":"J Cell Physiol"},{"issue":"4","key":"13564_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.prp.2012.12.006","volume":"209","author":"Y Niu","year":"2013","unstructured":"Niu Y, Wang S, Liu T, Zhang T, Wei X, Wang Y, et al. Expression of centrosomal tubulins associated with DNA ploidy in breast premalignant lesions and carcinoma. Pathol Res Pract. 2013;209(4):221\u20137.","journal-title":"Pathol Res Pract"},{"issue":"12","key":"13564_CR22","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1002\/1097-0142(19910615)67:12<3014::AID-CNCR2820671215>3.0.CO;2-U","volume":"67","author":"RA Badalament","year":"1991","unstructured":"Badalament RA, O\u2019Toole RV, Young DC, Drago JR. DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer. Cancer. 1991;67(12):3014\u201323.","journal-title":"Cancer"},{"key":"13564_CR23","doi-asserted-by":"crossref","unstructured":"Cyll K, Kleppe A, Kalsnes J, Vlatkovic L, Pradhan M, Kildal W et al. PTEN and DNA Ploidy Status by Machine learning in prostate Cancer. Cancers. 2021;13(17).","DOI":"10.3390\/cancers13174291"},{"issue":"4","key":"13564_CR24","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/ijc.32832","volume":"147","author":"E Ersvaer","year":"2020","unstructured":"Ersvaer E, Hveem TS, Vlatkovic L, Brennhovd B, Kleppe A, Tobin KAR, et al. Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer. Int J Cancer. 2020;147(4):1228\u201334.","journal-title":"Int J Cancer"},{"issue":"3","key":"13564_CR25","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10549-022-06587-3","volume":"193","author":"SC Hagenaars","year":"2022","unstructured":"Hagenaars SC, Vangangelt KMH, Van Pelt GW, Karancsi Z, Tollenaar R, Green AR, et al. Standardization of the tumor-stroma ratio scoring method for breast cancer research. Breast Cancer Res Treat. 2022;193(3):545\u201353.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"13564_CR26","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/annonc\/mdx794","volume":"29","author":"HE Danielsen","year":"2018","unstructured":"Danielsen HE, Hveem TS, Domingo E, Pradhan M, Kleppe A, Syvertsen RA, et al. Prognostic markers for colorectal cancer: estimating ploidy and stroma. Annals Oncology: Official J Eur Soc Med Oncol. 2018;29(3):616\u201323.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"issue":"2","key":"13564_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/his.13489","volume":"73","author":"GW van Pelt","year":"2018","unstructured":"van Pelt GW, Sandberg TP, Morreau H, Gelderblom H, van Krieken J, Tollenaar R, et al. The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact. Histopathology. 2018;73(2):197\u2013206.","journal-title":"Histopathology"},{"issue":"4","key":"13564_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41416-018-0202-y","volume":"119","author":"N Kemi","year":"2018","unstructured":"Kemi N, Eskuri M, Herva A, Lepp\u00e4nen J, Huhta H, Helminen O, et al. Tumour-stroma ratio and prognosis in gastric adenocarcinoma. Br J Cancer. 2018;119(4):435\u20139.","journal-title":"Br J Cancer"},{"issue":"5","key":"13564_CR29","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.3390\/curroncol29050263","volume":"29","author":"L Sullivan","year":"2022","unstructured":"Sullivan L, Pacheco RR, Kmeid M, Chen A, Lee H. Tumor stroma ratio and its significance in locally Advanced Colorectal Cancer. Curr Oncol (Toronto Ont). 2022;29(5):3232\u201341.","journal-title":"Curr Oncol (Toronto Ont)"},{"issue":"2","key":"13564_CR30","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/cas.15610","volume":"114","author":"W Tian","year":"2023","unstructured":"Tian W, Yang Y, Qin Q, Zhang L, Wang Z, Su L, et al. Vimentin and tumor-stroma ratio for neoadjuvant chemoradiotherapy response prediction in locally advanced rectal cancer. Cancer Sci. 2023;114(2):619\u201329.","journal-title":"Cancer Sci"},{"issue":"5","key":"13564_CR31","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1111\/odi.14203","volume":"29","author":"J Qiu","year":"2023","unstructured":"Qiu J, Jiang E, Shang Z. Prognostic value of tumor-stroma ratio in oral carcinoma: role of cancer-associated fibroblasts. Oral Dis. 2023;29(5):1967\u201378.","journal-title":"Oral Dis"},{"issue":"10","key":"13564_CR32","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1158\/1541-7786.MCR-17-0710","volume":"16","author":"H Jin","year":"2018","unstructured":"Jin H, Ham IH, Oh HJ, Bae CA, Lee D, Kim YB, et al. Inhibition of Discoidin Domain Receptor 1 prevents Stroma-Induced Peritoneal Metastasis in gastric carcinoma. Mol cancer Research: MCR. 2018;16(10):1590\u2013600.","journal-title":"Mol cancer Research: MCR"},{"issue":"7412","key":"13564_CR33","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature11273","volume":"488","author":"B Schuster-B\u00f6ckler","year":"2012","unstructured":"Schuster-B\u00f6ckler B, Lehner B. Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature. 2012;488(7412):504\u20137.","journal-title":"Nature"},{"issue":"7","key":"13564_CR34","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41568-021-00357-x","volume":"21","author":"S Zhao","year":"2021","unstructured":"Zhao S, Allis CD, Wang GG. The language of chromatin modification in human cancers. Nat Rev Cancer. 2021;21(7):413\u201330.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"13564_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41556-018-0258-1","volume":"21","author":"AM Valencia","year":"2019","unstructured":"Valencia AM, Kadoch C. Chromatin regulatory mechanisms and therapeutic opportunities in cancer. Nat Cell Biol. 2019;21(2):152\u201361.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"13564_CR36","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S1470-2045(17)30899-9","volume":"19","author":"A Kleppe","year":"2018","unstructured":"Kleppe A, Albregtsen F, Vlatkovic L, Pradhan M, Nielsen B, Hveem TS, et al. Chromatin organisation and cancer prognosis: a pan-cancer study. Lancet Oncol. 2018;19(3):356\u201369.","journal-title":"Lancet Oncol"},{"issue":"1","key":"13564_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13244-021-01110-6","volume":"12","author":"PB Panagiotopoulou","year":"2021","unstructured":"Panagiotopoulou PB, Courcoutsakis N, Tentes A, Prassopoulos P. CT imaging of peritoneal carcinomatosis with surgical correlation: a pictorial review. Insights into Imaging. 2021;12(1):168.","journal-title":"Insights into Imaging"},{"issue":"2","key":"13564_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1155\/2001\/657642","volume":"23","author":"G Haroske","year":"2001","unstructured":"Haroske G, Baak JP, Danielsen H, Giroud F, Gschwendtner A, Oberholzer M, et al. Fourth updated ESACP consensus report on diagnostic DNA image cytometry. Anal Cell Pathology: J Eur Soc Anal Cell Pathol. 2001;23(2):89\u201395.","journal-title":"Anal Cell Pathology: J Eur Soc Anal Cell Pathol"},{"issue":"6","key":"13564_CR39","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10495-016-1244-3","volume":"21","author":"W Hu","year":"2016","unstructured":"Hu W, Yang Y, Fan C, Ma Z, Deng C, Li T, et al. Clinical and pathological significance of N-Myc downstream-regulated gene 2 (NDRG2) in diverse human cancers. Apoptosis: Int J Program cell Death. 2016;21(6):675\u201382.","journal-title":"Apoptosis: Int J Program cell Death"},{"key":"13564_CR40","doi-asserted-by":"crossref","unstructured":"Li S, Dong R, Kang Z, Li H, Wu X, Li T, Exosomes. Another intercellular lipometabolic communication mediators in digestive system neoplasms? Cytokine & growth factor reviews. 2023;73:93\u2013100.","DOI":"10.1016\/j.cytogfr.2023.06.005"},{"key":"13564_CR41","doi-asserted-by":"crossref","unstructured":"Du M, Zhang S, Liu X, Xu C, Zhang X. Ploidy Status of Ovarian Cancer Cell lines and their association with gene expression profiles. Biomolecules. 2023;13(1).","DOI":"10.3390\/biom13010092"},{"issue":"7","key":"13564_CR42","first-page":"369","volume":"13","author":"P Sidaway","year":"2016","unstructured":"Sidaway P. Prostate cancer: Nucleotyping predicts recurrence post-RP. Nat Reviews Urol. 2016;13(7):369.","journal-title":"Nat Reviews Urol"},{"issue":"4","key":"13564_CR43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00535-012-0565-4","volume":"47","author":"E Oki","year":"2012","unstructured":"Oki E, Hisamatsu Y, Ando K, Saeki H, Kakeji Y, Maehara Y. Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers. J Gastroenterol. 2012;47(4):351\u20138.","journal-title":"J Gastroenterol"},{"key":"13564_CR44","doi-asserted-by":"crossref","unstructured":"Hveem TS, Nj\u00f8lstad TS, Nielsen B, Syvertsen RA, Nesheim JA, Kj\u00e6reng ML et al. Changes in chromatin structure in curettage specimens identifies high-risk patients in Endometrial Cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2017;26(1):61\u20137.","DOI":"10.1158\/1055-9965.EPI-16-0215"},{"issue":"1","key":"13564_CR45","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12885-019-5462-2","volume":"19","author":"TP Sandberg","year":"2019","unstructured":"Sandberg TP, Stuart M, Oosting J, Tollenaar R, Sier CFM, Mesker WE. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer. BMC Cancer. 2019;19(1):284.","journal-title":"BMC Cancer"},{"issue":"1","key":"13564_CR46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12885-023-10537-7","volume":"23","author":"J Yang","year":"2023","unstructured":"Yang J, Su H, Chen T, Chen X, Chen H, Li G, et al. Development and validation of nomogram of peritoneal metastasis in gastric cancer based on simplified clinicopathological features and serum tumor markers. BMC Cancer. 2023;23(1):64.","journal-title":"BMC Cancer"},{"issue":"3","key":"13564_CR47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","volume":"137","author":"KH Vousden","year":"2009","unstructured":"Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell. 2009;137(3):413\u201331.","journal-title":"Cell"},{"issue":"9","key":"13564_CR48","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrc2399","volume":"8","author":"DL Burkhart","year":"2008","unstructured":"Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer. 2008;8(9):671\u201382.","journal-title":"Nat Rev Cancer"},{"key":"13564_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-3-319-78127-3_6","volume":"1060","author":"AE Denton","year":"2018","unstructured":"Denton AE, Roberts EW, Fearon DT. Stromal cells in the Tumor Microenvironment. Adv Exp Med Biol. 2018;1060:99\u2013114.","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"13564_CR50","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582\u201398.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"13564_CR51","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41(1):49\u201361.","journal-title":"Immunity"},{"key":"13564_CR52","doi-asserted-by":"crossref","unstructured":"Massagu\u00e9 J. TGFbeta Cancer Cell. 2008;134(2):215\u201330.","DOI":"10.1016\/j.cell.2008.07.001"},{"issue":"10","key":"13564_CR53","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nrc909","volume":"2","author":"N Ferrara","year":"2002","unstructured":"Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer. 2002;2(10):795\u2013803.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"13564_CR54","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","volume":"161","author":"P Sharma","year":"2015","unstructured":"Sharma P, Allison JP. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell. 2015;161(2):205\u201314.","journal-title":"Cell"},{"issue":"7467","key":"13564_CR55","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature12626","volume":"501","author":"MR Junttila","year":"2013","unstructured":"Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013;501(7467):346\u201354.","journal-title":"Nature"},{"issue":"4","key":"13564_CR56","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.molonc.2011.06.001","volume":"5","author":"MS Luijsterburg","year":"2011","unstructured":"Luijsterburg MS, van Attikum H. Chromatin and the DNA damage response: the cancer connection. Mol Oncol. 2011;5(4):349\u201367.","journal-title":"Mol Oncol"},{"issue":"5","key":"13564_CR57","doi-asserted-by":"publisher","first-page":"e1500447","DOI":"10.1126\/sciadv.1500447","volume":"1","author":"C Kadoch","year":"2015","unstructured":"Kadoch C, Crabtree GR. Mammalian SWI\/SNF chromatin remodeling complexes and cancer: mechanistic insights gained from human genomics. Sci Adv. 2015;1(5):e1500447.","journal-title":"Sci Adv"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13564-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13564-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13564-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T11:03:43Z","timestamp":1737803023000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13564-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13564"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13564-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,25]]},"assertion":[{"value":"14 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental plan for this study was developed based on the ethical guidelines of the Helsinki Declaration and approved by the Ethics Committee of Renmin Hospital of Wuhan University (WDRY2022-K227). For patients participating in this study, informed consent has been obtained from themselves or their guardians and a written informed consent form has been signed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}